Read more about the article EMA and FDA Publish Common Principles for AI in Drug Development
EMA and FDA Publish Common Principles for AI in Drug Development - Lambda CRO

EMA and FDA Publish Common Principles for AI in Drug Development

Artificial intelligence is increasingly being applied across the medicine development lifecycle, including early research, clinical trials, manufacturing, and safety monitoring. As the use of AI expands, regulatory clarity has become…

Continue ReadingEMA and FDA Publish Common Principles for AI in Drug Development